ARIAD PHARMACEUTICALS INC Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31)
ARIAD PHARMACEUTICALS INC reported Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) of $19.6 for the 1-month period ending 2013-01-29, per its 10-Q filed 2013-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EquityIssuancePerShareAmount · last filed 2015-03-02
- 2013-01-29: Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 0 month $19.60; Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) $19.60; Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 1 month $19.60.
- 2011-12-20: Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 1 month $10.42.
- 2010-10-29: Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 1 month $3.70.
- 2009-02-25: Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) $1.69; Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 1 month $1.69.
USD
| Period end | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 0 month | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 1 month |
|---|---|---|---|
| 2013-01-29 | $19.60 10-Q · filed 2014-05-09 | $19.60 10-K · filed 2015-03-02 | $19.60 10-Q · filed 2013-05-10 |
| 2011-12-20 | $10.42 10-K · filed 2014-03-03 | ||
| 2010-10-29 | $3.70 10-K · filed 2013-03-01 | ||
| 2009-02-25 | $1.69 10-K · filed 2015-03-02 | $1.69 10-K · filed 2014-03-03 |
USD/shares
| Period end | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) |
|---|---|
| 2013-01-29 | $19.60 10-K · filed 2015-03-02 |
| 2009-02-25 | $1.69 10-K · filed 2015-03-02 |